Januvia - DPP-IV inhibitor for Type 2 Diabetes

Print-Icon
Print

Merck is conducting further trials on Januvia to test its efficacy with minimal side effects.
 
«Back



| 1 | 2 | 3 |

Browse More Images - Return to Project




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
Features
White Papers
Jobs & Careers
Industry News
Gallery
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area


RSS What is RSS
For every phase of your drug development